definiens: within the meaning of the PrivateSecurities Litigation Reform Act of 1995, regarding, among other things, [COMPANY] ’ freedom tooperate afforded by the license agreement with [COMPANY] and [COMPANY] ’ research, developmentand regulatory plans for AVXS-101 . Such forward - looking statements are based on current Page 30 / 31 Certain information has been omitted and filed separately with the Commission . Confidentialtreatment has been requested with respect to the omitted portions expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual results to differ materially from thoseprojected in its forward - looking statements . Meaningful factors which could cause actualresults to differ include, but are not limited to, the scope, progress, expansion, and costs ofdeveloping and commercializing [COMPANY] ’ product candidates ; regulatory developments in theU.S. and EU, as well as other factors discussed in the and the sections ofAveXis ’ Annual Report on Form 10 - K for the year ended December 31, 2017, filed with theSEC on February 28, 2018 . In addition to the risks described above and in the Annual Reportson Form 10 - K, Quarterly Reports on Form 10 - Q, Current Reports on Form 8 - K and other filingswith the SEC, other unknown or unpredictable factors also could affect [COMPANY] ’ results . Therecan be no assurance that the actual results or developments anticipated by [COMPANY] will berealized or, even if substantially realized, that they will have the expected consequences to, or effects on, [COMPANY] . Therefore, no assurance can be given that the outcomes stated insuch forward- looking statements and estimates will be achieved